30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Fusion Pharmaceuticals Inc (FUSN)

Track

Stock chart
Ticker: FUSN Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
O'Leary, James John
Senior Officer of Issuer
1 sale — total 6,300 USD
Sale 4 Jun 2024
Value US$2,766,063.56 | Price 137.30 | Shares 25,090
Sale 4 Jun 2024
Value US$4,572,477.72 | Price 107.66 | Shares 40,436
Proposed sale 14 Dec 2023
Value US$121,511.00 | Price 5.50 | Shares 22,093
Proposed sale 8 Dec 2023
Value US$127,034.00 | Price 5.75 | Shares 22,093
Buy 11 Nov 2022
Value US$100,181.34 | Price 2.38 | Shares 42,093
Buy 11 Aug 2022
Value US$90,132.00 | Price 2.03 | Shares 44,400
Planned sale 27 Apr 2022
Value US$27,201.33 | Price 6.03 | Shares 4,511
Planned sale 26 Apr 2022
Value US$13,032.29 | Price 6.07 | Shares 2,147
Planned sale 25 Apr 2022
Value US$12,277.08 | Price 6.03 | Shares 2,036
Planned sale 21 Apr 2022
Value US$5,541.22 | Price 6.01 | Shares 922
Planned sale 20 Apr 2022
Value US$2,209.34 | Price 6.02 | Shares 367
Planned sale 13 Apr 2022
Value US$76,881.54 | Price 6.41 | Shares 11,994
Planned sale 12 Apr 2022
Value US$129,610.50 | Price 7.10 | Shares 18,255
Planned sale 11 Apr 2022
Value US$19,162.00 | Price 7.37 | Shares 2,600
Planned sale 8 Apr 2022
Value US$6,211.52 | Price 7.52 | Shares 826
Planned sale 7 Apr 2022
Value US$9,487.80 | Price 7.56 | Shares 1,255
Planned sale 6 Apr 2022
Value US$758.00 | Price 7.58 | Shares 100
Planned sale 5 Apr 2022
Value US$16,107.00 | Price 7.67 | Shares 2,100
Planned sale 4 Apr 2022
Value US$5,467.00 | Price 7.81 | Shares 700
Planned sale 1 Apr 2022
Value US$7,750.00 | Price 7.75 | Shares 1,000
Planned sale 30 Mar 2022
Value US$2,256.00 | Price 7.52 | Shares 300
Planned sale 29 Mar 2022
Value US$1,504.00 | Price 7.52 | Shares 200
Planned sale 28 Mar 2022
Value US$72,480.00 | Price 7.55 | Shares 9,600
Planned sale 25 Mar 2022
Value US$3,710.00 | Price 7.42 | Shares 500
Planned sale 23 Mar 2022
Value US$750.00 | Price 7.50 | Shares 100
Planned sale 22 Mar 2022
Value US$30,120.00 | Price 7.53 | Shares 4,000
Planned sale 21 Mar 2022
Value US$5,222.00 | Price 7.46 | Shares 700
Planned sale 21 Mar 2022
Value US$11,205.00 | Price 7.47 | Shares 1,500
Planned sale 18 Mar 2022
Value US$9,162.44 | Price 7.61 | Shares 1,204
Planned sale 17 Mar 2022
Value US$6,759.00 | Price 7.51 | Shares 900
Planned sale 16 Mar 2022
Value US$699.00 | Price 6.99 | Shares 100
Planned sale 15 Mar 2022
Value US$712.00 | Price 7.12 | Shares 100
Planned sale 14 Mar 2022
Value US$9,048.00 | Price 6.96 | Shares 1,300
Planned sale 11 Mar 2022
Value US$713.00 | Price 7.13 | Shares 100
Planned sale 10 Mar 2022
Value US$13,414.00 | Price 7.06 | Shares 1,900
Planned sale 9 Mar 2022
Value US$5,704.68 | Price 6.94 | Shares 822
Planned sale 8 Mar 2022
Value US$20,787.68 | Price 6.92 | Shares 3,004
Planned sale 7 Mar 2022
Value US$21,669.00 | Price 6.99 | Shares 3,100
Planned sale 4 Mar 2022
Value US$61,488.00 | Price 7.32 | Shares 8,400
Planned sale 3 Mar 2022
Value US$1,456.00 | Price 7.28 | Shares 200
Planned sale 2 Mar 2022
Value US$197,502.24 | Price 7.44 | Shares 26,546
Planned sale 1 Mar 2022
Value US$6,242.39 | Price 7.37 | Shares 847
Planned sale 28 Feb 2022
Value US$22,940.00 | Price 7.40 | Shares 3,100
Planned sale 25 Feb 2022
Value US$61,710.64 | Price 7.57 | Shares 8,152
Planned sale 24 Feb 2022
Value US$18,525.00 | Price 7.41 | Shares 2,500
Planned sale 23 Feb 2022
Value US$227,653.23 | Price 7.77 | Shares 29,299
Planned sale 22 Feb 2022
Value US$32,185.00 | Price 7.85 | Shares 4,100
Planned sale 18 Feb 2022
Value US$38,596.24 | Price 7.88 | Shares 4,898
Planned sale 17 Feb 2022
Value US$13,566.00 | Price 7.98 | Shares 1,700
Planned sale 16 Feb 2022
Value US$265,283.98 | Price 7.99 | Shares 33,202
Planned sale 15 Feb 2022
Value US$104,958.00 | Price 8.33 | Shares 12,600
Buy 19 Aug 2021
Value US$24,150.00 | Price 8.05 | Shares 3,000
Buy 18 Aug 2021
Value US$1,376.55 | Price 8.05 | Shares 171
Sale 24 Dec 2020
Value US$19,514.88 | Price 12.32 | Shares 1,584
Sale 24 Dec 2020
Value US$8,389.92 | Price 12.32 | Shares 681
Sale 24 Dec 2020
Value US$5,605.60 | Price 12.32 | Shares 455
Sale 24 Dec 2020
Value US$5,778.08 | Price 12.32 | Shares 469
Sale 24 Dec 2020
Value US$7,527.52 | Price 12.32 | Shares 611
Sale 23 Dec 2020
Value US$23,602.95 | Price 12.39 | Shares 1,905
Sale 23 Dec 2020
Value US$10,147.41 | Price 12.39 | Shares 819
Sale 23 Dec 2020
Value US$6,777.33 | Price 12.39 | Shares 547
Sale 23 Dec 2020
Value US$6,987.96 | Price 12.39 | Shares 564
Sale 23 Dec 2020
Value US$9,094.26 | Price 12.39 | Shares 734
Buy 30 Jun 2020
Value US$4,250,000.00 | Price 17.00 | Shares 250,000
Buy 30 Jun 2020
Value US$3,265,700.00 | Price 17.00 | Shares 192,100
Buy 30 Jun 2020
Value US$12,000,300.00 | Price 17.00 | Shares 705,900
Buy 30 Jun 2020
Value US$4,080,000.00 | Price 17.00 | Shares 240,000
Buy 30 Jun 2020
Value US$3,265,700.00 | Price 17.00 | Shares 192,100
Buy 30 Jun 2020
Value US$12,000,300.00 | Price 17.00 | Shares 705,900
Buy 30 Jun 2020
Value US$12,325,000.00 | Price 17.00 | Shares 725,000
Buy 30 Jun 2020
Value US$4,080,000.00 | Price 17.00 | Shares 240,000
Buy 30 Jun 2020
Value US$5,100.00 | Price 17.00 | Shares 300
Buy 30 Jun 2020
Value US$149,991.00 | Price 17.00 | Shares 8,823
Buy 30 Jun 2020
Value US$110,500.00 | Price 17.00 | Shares 6,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-05 2024-06-04 S Sale
O'Leary, James John

Senior Officer of Issuer

Officer
25,090
137.30
US$2,766,064 		25,090 137.30 US$2,766,064
2024-06-05 2024-06-04 S Sale
Crowley, John Joseph

Senior Officer of Issuer

Officer
40,436
107.66
US$4,572,478 		40,436 107.66 US$4,572,478
2023-12-14 2023-12-14 PrS Proposed sale
2.5
Chau Q. Khuong

Affiliate
17,479
371.47
US$4,736,468 		17,479 371.47 US$4,736,468
2023-12-08 2023-12-08 PrS Proposed sale
2.5
Chau Q. Khuong

Affiliate
22,093
5.75
US$127,034 		22,093 5.75 US$127,034
2022-11-14 2022-11-11 B Purchase
3.2
Khuong, Chau Quang

Director of Issuer

Non-Executive Director
42,093
2.38
US$100,181 		42,093 2.38 US$100,181
2022-08-11 2022-08-11 B Purchase
3.8
GANNON STEVEN
Non-Executive Director
44,400 +370.0%
2.03
US$90,132 		44,400 +370.0% 2.03 US$90,132
2022-04-27 2022-04-27 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
4,511 -1.4%
6.03
US$27,201 		4,511 -1.4% 6.03 US$27,201
2022-04-27 2022-04-26 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
2,147 -0.7%
6.07
US$13,032 		2,147 -0.7% 6.07 US$13,032
2022-04-27 2022-04-25 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
2,036 -0.6%
6.03
US$12,277 		2,036 -0.6% 6.03 US$12,277
2022-04-22 2022-04-21 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
922 -0.3%
6.01
US$5,541 		922 -0.3% 6.01 US$5,541
2022-04-22 2022-04-20 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
367 -0.1%
6.02
US$2,209 		367 -0.1% 6.02 US$2,209
2022-04-13 2022-04-13 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
11,994 -3.5%
6.41
US$76,882 		11,994 -3.5% 6.41 US$76,882
2022-04-13 2022-04-12 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
18,255 -5.1%
7.10
US$129,610 		18,255 -5.1% 7.10 US$129,610
2022-04-13 2022-04-11 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
2,600 -0.7%
7.37
US$19,162 		2,600 -0.7% 7.37 US$19,162
2022-04-08 2022-04-08 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
826 -0.2%
7.52
US$6,212 		826 -0.2% 7.52 US$6,212
2022-04-08 2022-04-07 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
1,255 -0.3%
7.56
US$9,488 		1,255 -0.3% 7.56 US$9,488
2022-04-08 2022-04-06 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
100 -0.0%
7.58
US$758 		100 -0.0% 7.58 US$758
2022-04-05 2022-04-05 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
2,100 -0.6%
7.67
US$16,107 		2,100 -0.6% 7.67 US$16,107
2022-04-05 2022-04-04 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
700 -0.2%
7.81
US$5,467 		700 -0.2% 7.81 US$5,467
2022-04-05 2022-04-01 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
1,000 -0.3%
7.75
US$7,750 		1,000 -0.3% 7.75 US$7,750
2022-04-01 2022-03-30 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
300 -0.1%
7.52
US$2,256 		300 -0.1% 7.52 US$2,256
2022-03-29 2022-03-29 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
200 -0.1%
7.52
US$1,504 		200 -0.1% 7.52 US$1,504
2022-03-29 2022-03-28 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
9,600 -2.5%
7.55
US$72,480 		9,600 -2.5% 7.55 US$72,480
2022-03-29 2022-03-25 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
500 -0.1%
7.42
US$3,710 		500 -0.1% 7.42 US$3,710
2022-03-24 2022-03-23 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
100 -0.0%
7.50
US$750 		100 -0.0% 7.50 US$750
2022-03-24 2022-03-22 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
4,000 -1.0%
7.53
US$30,120 		4,000 -1.0% 7.53 US$30,120
2022-03-24 2022-03-21 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
700 -0.2%
7.46
US$5,222 		700 -0.2% 7.46 US$5,222
2022-03-21 2022-03-21 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
1,500 -0.4%
7.47
US$11,205 		1,500 -0.4% 7.47 US$11,205
2022-03-21 2022-03-18 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
1,204 -0.3%
7.61
US$9,162 		1,204 -0.3% 7.61 US$9,162
2022-03-21 2022-03-17 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
900 -0.2%
7.51
US$6,759 		900 -0.2% 7.51 US$6,759
2022-03-16 2022-03-16 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
100 -0.0%
6.99
US$699 		100 -0.0% 6.99 US$699
2022-03-16 2022-03-15 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
100 -0.0%
7.12
US$712 		100 -0.0% 7.12 US$712
2022-03-16 2022-03-14 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
1,300 -0.3%
6.96
US$9,048 		1,300 -0.3% 6.96 US$9,048
2022-03-14 2022-03-11 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
100 -0.0%
7.13
US$713 		100 -0.0% 7.13 US$713
2022-03-14 2022-03-10 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
1,900 -0.5%
7.06
US$13,414 		1,900 -0.5% 7.06 US$13,414
2022-03-14 2022-03-09 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
822 -0.2%
6.94
US$5,705 		822 -0.2% 6.94 US$5,705
2022-03-08 2022-03-08 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
3,004 -0.8%
6.92
US$20,788 		3,004 -0.8% 6.92 US$20,788
2022-03-08 2022-03-07 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
3,100 -0.8%
6.99
US$21,669 		3,100 -0.8% 6.99 US$21,669
2022-03-08 2022-03-04 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
8,400 -2.1%
7.32
US$61,488 		8,400 -2.1% 7.32 US$61,488
2022-03-03 2022-03-03 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
200 -0.0%
7.28
US$1,456 		200 -0.0% 7.28 US$1,456
2022-03-03 2022-03-02 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
26,546 -6.2%
7.44
US$197,502 		26,546 -6.2% 7.44 US$197,502
2022-03-03 2022-03-01 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
847 -0.2%
7.37
US$6,242 		847 -0.2% 7.37 US$6,242
2022-02-28 2022-02-28 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
3,100 -0.7%
7.40
US$22,940 		3,100 -0.7% 7.40 US$22,940
2022-02-28 2022-02-25 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
8,152 -1.8%
7.57
US$61,711 		8,152 -1.8% 7.57 US$61,711
2022-02-28 2022-02-24 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
2,500 -0.6%
7.41
US$18,525 		2,500 -0.6% 7.41 US$18,525
2022-02-23 2022-02-23 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
29,299 -6.2%
7.77
US$227,653 		29,299 -6.2% 7.77 US$227,653
2022-02-23 2022-02-22 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
4,100 -0.9%
7.85
US$32,185 		4,100 -0.9% 7.85 US$32,185
2022-02-23 2022-02-18 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
4,898 -1.0%
7.88
US$38,596 		4,898 -1.0% 7.88 US$38,596
2022-02-17 2022-02-17 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
1,700 -0.3%
7.98
US$13,566 		1,700 -0.3% 7.98 US$13,566
2022-02-17 2022-02-16 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
33,202 -6.4%
7.99
US$265,284 		33,202 -6.4% 7.99 US$265,284
2022-02-17 2022-02-15 PlS Planned sale
Valliant John

Chief Executive Officer

Executive Director
12,600 -2.4%
8.33
US$104,958 		12,600 -2.4% 8.33 US$104,958
2021-08-20 2021-08-19 B Purchase
3.8
GANNON STEVEN
Non-Executive Director
3,000 +48.6%
8.05
US$24,150 		3,000 +48.6% 8.05 US$24,150
2021-08-20 2021-08-18 B Purchase
3.8
GANNON STEVEN
Non-Executive Director
171 +2.9%
8.05
US$1,377 		171 +2.9% 8.05 US$1,377
2020-12-29 2020-12-24 S Sale
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
1,584 -0.1%
12.32
US$19,515 		1,584 -0.1% 12.32 US$19,515
2020-12-29 2020-12-24 S Sale
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
681 -0.1%
12.32
US$8,390 		681 -0.1% 12.32 US$8,390
2020-12-29 2020-12-24 S Sale
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
455 -0.1%
12.32
US$5,606 		455 -0.1% 12.32 US$5,606
2020-12-29 2020-12-24 S Sale
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
469 -0.1%
12.32
US$5,778 		469 -0.1% 12.32 US$5,778
2020-12-29 2020-12-24 S Sale
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
611 -0.1%
12.32
US$7,528 		611 -0.1% 12.32 US$7,528
2020-12-28 2020-12-23 S Sale
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
1,905 -0.1%
12.39
US$23,603 		1,905 -0.1% 12.39 US$23,603
2020-12-28 2020-12-23 S Sale
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
819 -0.1%
12.39
US$10,147 		819 -0.1% 12.39 US$10,147
2020-12-28 2020-12-23 S Sale
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
547 -0.1%
12.39
US$6,777 		547 -0.1% 12.39 US$6,777
2020-12-28 2020-12-23 S Sale
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
564 -0.1%
12.39
US$6,988 		564 -0.1% 12.39 US$6,988
2020-12-28 2020-12-23 S Sale
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
734 -0.1%
12.39
US$9,094 		734 -0.1% 12.39 US$9,094
2020-07-02 2020-06-30 B Purchase
3.7
TPG Group Holdings (SBS) Advisors, Inc.
250,000 +10.9%
17.00
US$4,250,000 		250,000 +10.9% 17.00 US$4,250,000
2020-07-02 2020-06-30 B Purchase
2.5
Khuong Chau Quang
Non-Executive Director
192,100 +inf%
17.00
US$3,265,700 		192,100 +inf% 17.00 US$3,265,700
2020-07-02 2020-06-30 B Purchase
2.5
Khuong Chau Quang
Non-Executive Director
705,900 +31.7%
17.00
US$12,000,300 		705,900 +31.7% 17.00 US$12,000,300
2020-07-02 2020-06-30 B Purchase
0.6
Christenson Johan
Non-Executive Director
240,000 +6.7%
17.00
US$4,080,000 		240,000 +6.7% 17.00 US$4,080,000
2020-07-02 2020-06-30 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director
192,100 +inf%
17.00
US$3,265,700 		192,100 +inf% 17.00 US$3,265,700
2020-07-02 2020-06-30 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director
705,900 +31.7%
17.00
US$12,000,300 		705,900 +31.7% 17.00 US$12,000,300
2020-07-02 2020-06-30 B Purchase
1.5
JOHNSON & JOHNSON
Large shareholder
725,000 +24.6%
17.00
US$12,325,000 		725,000 +24.6% 17.00 US$12,325,000
2020-07-02 2020-06-30 B Purchase
0.6
HealthCap VII, L.P.
Large shareholder
240,000 +6.7%
17.00
US$4,080,000 		240,000 +6.7% 17.00 US$4,080,000
2020-07-02 2020-06-30 B Purchase
0.6
O'Leary James J

Chief Medical Officer

Officer
300 +inf%
17.00
US$5,100 		300 +inf% 17.00 US$5,100
2020-07-02 2020-06-30 B Purchase
3.4
Preston Heather
Non-Executive Director
8,823 +inf%
17.00
US$149,991 		8,823 +inf% 17.00 US$149,991
2020-07-02 2020-06-30 B Purchase
0.6
Crowley John J

Chief Financial Officer

Officer
6,500 +inf%
17.00
US$110,500 		6,500 +inf% 17.00 US$110,500
Explore more

More insider trading research around Fusion Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America